MEK (MAPKK) inhibitors. Part 2: structure–activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines

Seeger, 1995, FASEB J., 9, 726, 10.1096/fasebj.9.9.7601337 Cobb, 1995, J. Biol. Chem., 270, 14843, 10.1074/jbc.270.25.14843 Schaeffer, 1999, Mol. Cell. Biol., 19, 2435, 10.1128/MCB.19.4.2435 Garrington, 1999, Curr. Opin. Cell. Biol., 11, 211, 10.1016/S0955-0674(99)80028-3 Bos, 1989, Cancer Res., 49, 4682 Kiaris, 1995, Int. J. Oncol., 7, 413 Callans, 1995, Annu. Surg. Oncol., 2, 38, 10.1007/BF02303700 Berger, 1997, J. Surg. Res., 69, 199, 10.1006/jsre.1997.5022 El-Ashry, 1997, Oncogene, 15, 423, 10.1038/sj.onc.1201198 Fang, 1993, Carcinogenesis, 14, 669, 10.1093/carcin/14.4.669 Bisgaard, 1997, Invasion Metastasis, 17, 240 Scully, 1991, Int. J. Cancer, 48, 128, 10.1002/ijc.2910480123 Hampton, 1990, Cancer Res., 50, 7460 Oka, 1995, Cancer Res., 55, 4182 Sivaraman, 1997, J. Clin. Invest., 99, 1478, 10.1172/JCI119309 Kono, 1998, Jpn. J. Cancer Res., 89, 903, 10.1111/j.1349-7006.1998.tb00647.x Towatari, 1997, Leukemia, 11, 479, 10.1038/sj.leu.2400617 Mandell, 1998, Am. J. Pathol., 153, 1411, 10.1016/S0002-9440(10)65728-8 Mishima, 1998, Modern Pathol., 11, 886 Hoshino, 1999, Oncogene, 18, 813, 10.1038/sj.onc.1202367 Stein, 1996, Annu. Rep. Med. Chem., 31, 289, 10.1016/S0065-7743(08)60468-6 Sedlacek, 2000, Drugs, 59, 435, 10.2165/00003495-200059030-00004 Levitt, 1999, Invest. New Drugs, 17, 213, 10.1023/A:1006372102543 Cohen, 1999, Curr. Opin. Chem. Biol., 3, 459, 10.1016/S1367-5931(99)80067-2 Levitzki, 1999, Pharmacol. Ther., 82, 231, 10.1016/S0163-7258(98)00066-7 Monia, 1997, Anti-Cancer Drug Des., 12, 327 Geiger, 1997, Clin. Cancer Res., 3, 1179 Lau, 1998, Oncogene, 16, 1899, 10.1038/sj.onc.1201709 Simon, 1999, Br. J. Cancer, 80, 1412, 10.1038/sj.bjc.6690537 Dudley, 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 7686, 10.1073/pnas.92.17.7686 Alessi, 1995, J. Biol. Chem., 270, 13585, 10.1074/jbc.270.23.13585 Sebolt-Leopold, 1999, Nat. Med., 5, 810, 10.1038/10533 Nishio, 1999, Int. J. Oncol., 14, 461 Favata, 1998, J. Biol. Chem., 273, 18623, 10.1074/jbc.273.29.18623 Denny, 1996, Clin. Exp. Pharmacol. Physiol., 23, 424, 10.1111/j.1440-1681.1996.tb02752.x Fry, 1999, Pharmacol. Ther., 82, 207, 10.1016/S0163-7258(98)00050-3 Smaill, 1999, J. Med. Chem., 42, 1803, 10.1021/jm9806603 Discafani, 1999, Biochem. Pharmacol., 57, 917, 10.1016/S0006-2952(98)00356-6 Wissner, 2000, J. Med. Chem., 43, 3244, 10.1021/jm000206a Wang, 2000, Bioorg. Med. Chem. Lett., 10, 2477, 10.1016/S0960-894X(00)00493-5 Boschelli, 2001, J. Med. Chem., 44, 822, 10.1021/jm000420z Zhang, 2000, Bioorg. Med. Chem. Lett., 10, 2825, 10.1016/S0960-894X(00)00580-1 (b) Zhang, N.; Wu, B.; Powell, D.; Wissner, A.; Kovacs, E. D.; Toral-Barza, L.; Kohler, C. In Frontiers of Biotechnology & Pharmaceuticals; Science: New York, 2000; Vol. 1, pp 305–313. Ferrell, 1997, Trends Biochem. Sci., 22, 288, 10.1016/S0968-0004(97)82217-7 Ferrell, 1998, Trends Biochem. Sci., 23, 461, 10.1016/S0968-0004(98)01316-4